b 859
Pill imprint b 859 has been identified as Flecainide acetate 50 mg.
Flecainide is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter; paroxysmal supraventricular tachycardia (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy.
Flecainide 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Flecainide acetate Images
- Imprint:
-
b
859 - Strength:
- 50 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0859
Advertisement
More Flecainide Acetate resources
- Flecainide (Wolters Kluwer)
- flecainide (Cerner Multum)
- flecainide (Micromedex) - Includes Dosage Information
- Flecainide Acetate (AHFS DI)
- Flecainide (FDA)
- Flecainide Acetate (Wolters Kluwer)
Search Again
